
TY  - JOUR
TI  - Abtracts
JO  - Journal of Medical Primatology
JA  - J Med Primatol
VL  - 45
IS  - 5
SN  - 0047-2565
UR  - https://doi.org/10.1111/jmp.12245
DO  - doi:10.1111/jmp.12245
SP  - 222
EP  - 274
PY  - 2016
ER  - 

TY  - JOUR
TI  - Poster Session 5
JO  - European Journal of Heart Failure Supplements
JA  - European Journal of Heart Failure Supplements
VL  - 10
IS  - S1
SN  - 1567-4215
UR  - https://doi.org/10.1093/eurjhf/hsr011
DO  - doi:10.1093/eurjhf/hsr011
SP  - S218
EP  - S263
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Veterinary Internal Medicine
VL  - 19
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.2005.tb00640.x
DO  - doi:10.1111/j.1939-1676.2005.tb00640.x
SP  - 399
EP  - 488
PY  - 2005
ER  - 

TY  - JOUR
AU  - REECE, R L
AU  - IRELAND, L.
AU  - BARR, D A
TI  - Infectious sinusitis associated with Mycoplasma gallisepticum in game-birds
JO  - Australian Veterinary Journal
VL  - 63
IS  - 5
SN  - 0005-0423
UR  - https://doi.org/10.1111/j.1751-0813.1986.tb02963.x
DO  - doi:10.1111/j.1751-0813.1986.tb02963.x
SP  - 167
EP  - 168
PY  - 1986
ER  - 

TY  - JOUR
AU  - REECE, R L
AU  - IRELAND, L.
AU  - SCOTT, P C
TI  - Mycoplasmosis in racing pigeons
JO  - Australian Veterinary Journal
VL  - 63
IS  - 5
SN  - 0005-0423
UR  - https://doi.org/10.1111/j.1751-0813.1986.tb02962.x
DO  - doi:10.1111/j.1751-0813.1986.tb02962.x
SP  - 166
EP  - 167
PY  - 1986
ER  - 

TY  - JOUR
TI  - ACVIM Abstracts
JO  - Journal of Veterinary Internal Medicine
VL  - 19
IS  - 3
SN  - 0891-6640
UR  - https://doi.org/10.1111/j.1939-1676.2005.tb02714.x
DO  - doi:10.1111/j.1939-1676.2005.tb02714.x
SP  - 386
EP  - 488
PY  - 2005
ER  - 

TY  - JOUR
TI  - ESSR ABSTRACTS 2010
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 97
IS  - S4
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.7158
DO  - doi:10.1002/bjs.7158
SP  - S1
EP  - S58
PY  - 2010
AB  - Abstract The 45th Congress of the European Society for Surgical Research takes place this year in Geneva, Switzerland, 9?12 June 2010, under the presidency of Mustafa Cikirikcioglu, MD, PhD. Copyright ? 2010 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - 2nd Trends in Medical Mycology
JO  - Mycoses
VL  - 48
IS  - s2
SN  - 0933-7407
UR  - https://doi.org/10.1111/j.1439-0507.2005.01157.x
DO  - doi:10.1111/j.1439-0507.2005.01157.x
SP  - 7
EP  - 103
PY  - 2005
ER  - 

TY  - JOUR
AU  - Kou, Zhifeng
AU  - VandeVord, Pamela J.
TI  - Traumatic white matter injury and glial activation: From basic science to clinics
JO  - Glia
JA  - Glia
VL  - 62
IS  - 11
SN  - 0894-1491
UR  - https://doi.org/10.1002/glia.22690
DO  - doi:10.1002/glia.22690
SP  - 1831
EP  - 1855
KW  - traumatic brain injury
KW  - traumatic axonal injury
KW  - diffuse axonal injury
KW  - glial activation
KW  - neuroinflammation
KW  - microglia
KW  - astrocyte
KW  - biomarkers
KW  - magnetic resonance imaging
KW  - neuroimaging
KW  - diffusion tensor imaging
PY  - 2014
AB  - An improved understanding and characterization of glial activation and its relationship with white matter injury will likely serve as a novel treatment target to curb post injury inflammation and promote axonal remyelination after brain trauma. Traumatic brain injury (TBI) is a significant public healthcare burden and a leading cause of death and disability in the United States. Particularly, traumatic white matter (WM) injury or traumatic axonal injury has been reported as being associated with patients' poor outcomes. However, there is very limited data reporting the importance of glial activation after TBI and its interaction with WM injury. This article presents a systematic review of traumatic WM injury and the associated glial activation, from basic science to clinical diagnosis and prognosis, from advanced neuroimaging perspective. It concludes that there is a disconnection between WM injury research and the essential role of glia which serve to restore a healthy environment for axonal regeneration following WM injury. Particularly, there is a significant lack of non-invasive means to characterize the complex pathophysiology of WM injury and glial activation in both animal models and in humans. An improved understanding and characterization of the relationship between glia and WM injury will likely serve as a novel treatment target to curb post injury inflammation and promote axonal remyelination. GLIA 2014;62:1831?1855
ER  - 

TY  - JOUR
AU  - Gentile, Pietro
AU  - Scioli, Maria Giovanna
AU  - Bielli, Alessandra
AU  - Orlandi, Augusto
AU  - Cervelli, Valerio
TI  - Concise Review: The Use of Adipose-Derived Stromal Vascular Fraction Cells and Platelet Rich Plasma in Regenerative Plastic Surgery
JO  - STEM CELLS
JA  - Stem Cells
VL  - 35
IS  - 1
SN  - 1066-5099
UR  - https://doi.org/10.1002/stem.2498
DO  - doi:10.1002/stem.2498
SP  - 117
EP  - 134
KW  - Regenerative medicine
KW  - Tissue engineering
KW  - Biomaterials
KW  - Stromal vascular fraction
KW  - Adipose-derived stem cells
KW  - Platelet rich plasma
PY  - 2017
AB  - Abstract Tissue engineering has emerged at the intersection of numerous disciplines to meet a global clinical need for technologies to promote the regeneration of tissues. Recently, many authors have focused their attention on mesenchymal stem/stromal cells (MSCs) for their capacity to differentiate into many cell lineages. The most widely studied cell types are bone marrow mesenchymal stem cells and adipose-derived stem cells (ASCs), which display similar results. Biomaterials, cells, and growth factors are needed to design a regenerative plastic surgery approach in the treatment of organ and tissue defects, but not all tissues are created equal. The aim of this article is to describe the advances in tissue engineering through the use of ASCs, platelet rich plasma, and biomaterials to enable regeneration of damaged complex tissue. Stem Cells 2017;35:117?134
ER  - 

TY  - JOUR
TI  - Abstracts of papers,** 2001 Annal Meeting Walt Disney Dolphin Orlando, Florida, March 6–10, 2001*
JO  - Clinical Pharmacology & Therapeutics
JA  - Clinical Pharmacology & Therapeutics
VL  - 69
IS  - 2
SN  - 0009-9236
UR  - https://doi.org/10.1016/S0009-9236(01)90087-6a
DO  - doi:10.1016/S0009-9236(01)90087-6a
SP  - P1
EP  - P95
PY  - 2001
AB  - Clinical Pharmacology  doi: 10.1016/S0009-9236(01)90087-6a
ER  - 

TY  - JOUR
TI  - Poster Presentation
JO  - Acta Anaesthesiologica Scandinavica
VL  - 53
IS  - s119
SN  - 0001-5172
UR  - https://doi.org/10.1111/j.1399-6576.2009.02005.x
DO  - doi:10.1111/j.1399-6576.2009.02005.x
SP  - 62
EP  - 78
PY  - 2009
ER  - 

TY  - JOUR
TI  - Posters
JO  - Journal of the European Academy of Dermatology and Venereology
VL  - 9
IS  - S1
SN  - 0926-9959
UR  - https://doi.org/10.1111/j.1468-3083.1997.tb01080.x
DO  - doi:10.1111/j.1468-3083.1997.tb01080.x
SP  - S153
EP  - S238
PY  - 1997
ER  - 

TY  - JOUR
TI  - Pathological Society of Great Britain and Ireland. 175th meeting, 2–4 July 1997
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 182
IS  - 1
SN  - 0022-3417
UR  - https://doi.org/10.1002/path.1711820102
DO  - doi:10.1002/path.1711820102
SP  - A1
EP  - A49
PY  - 1997
ER  - 

TY  - JOUR
AU  - Jeon, Min-Tae
AU  - Moon, Gyeong Joon
AU  - Kim, Sehwan
AU  - Choi, Minji
AU  - Oh, Yong-Seok
AU  - Kim, Dong Woon
AU  - Kim, Hyung-Jun
AU  - Lee, Kea Joo
AU  - Choe, Youngshik
AU  - Ha, Chang Man
AU  - Jang, Il-Sung
AU  - Nakamura, Michiko
AU  - McLean, Catriona
AU  - Chung, Won-Suk
AU  - Shin, Won-Ho
AU  - Lee, Seok-Geun
AU  - Kim, Sang Ryong
C8  - 2019-BJP-0247-RP.R2
TI  - Neurotrophic interactions between neurons and astrocytes following AAV1-Rheb(S16H) transduction in the hippocampus in vivo
JO  - British Journal of Pharmacology
JA  - Br J Pharmacol
VL  - 177
IS  - 3
SN  - 0007-1188
UR  - https://doi.org/10.1111/bph.14882
DO  - doi:10.1111/bph.14882
SP  - 668
EP  - 686
PY  - 2020
AB  - Background and Purpose We recently reported that AAV1-Rheb(S16H) transduction could protect hippocampal neurons through the induction of brain-derived neurotrophic factor (BDNF) in the rat hippocampus in vivo. It is still unclear how neuronal BDNF produced by AAV1-Rheb(S16H) transduction induces neuroprotective effects in the hippocampus and whether its up-regulation contributes to the enhance of a neuroprotective system in the adult brain. Experimental Approach To determine the presence of a neuroprotective system in the hippocampus of patients with Alzheimer's disease (AD), we examined the levels of glial fibrillary acidic protein, BDNF and ciliary neurotrophic factor (CNTF) and their receptors, tropomyocin receptor kinase B (TrkB) and CNTF receptor α(CNTFRα), in the hippocampus of AD patients. We also determined whether AAV1-Rheb(S16H) transduction stimulates astroglial activation and whether reactive astrocytes contribute to neuroprotection in models of hippocampal neurotoxicity in vivo and in vitro. Key Results AD patients may have a potential neuroprotective system, demonstrated by increased levels of full-length TrkB and CNTFRα in the hippocampus. Further AAV1-Rheb(S16H) transduction induced sustained increases in the levels of full-length TrkB and CNTFRα in reactive astrocytes and hippocampal neurons. Moreover, neuronal BDNF produced by Rheb(S16H) transduction of hippocampal neurons induced reactive astrocytes, resulting in CNTF production through the activation of astrocytic TrkB and the up-regulation of neuronal BDNF and astrocytic CNTF which had synergistic effects on the survival of hippocampal neurons in vivo. Conclusions and Implications The results demonstrated that Rheb(S16H) transduction of hippocampal neurons could strengthen the neuroprotective system and this intensified system may have a therapeutic value against neurodegeneration in the adult brain.
ER  - 

TY  - JOUR
TI  - Poster Sessions
JO  - Allergy
VL  - 64
IS  - s90
SN  - 0105-4538
UR  - https://doi.org/10.1111/j.1398-9995.2009.02076.x
DO  - doi:10.1111/j.1398-9995.2009.02076.x
SP  - 179
EP  - 538
PY  - 2009
ER  - 

TY  - JOUR
TI  - Friday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other)
JO  - HPB
JA  - HPB
VL  - 16
IS  - S1
SN  - 1365-182X
UR  - https://doi.org/10.1111/hpb.12223_6
DO  - doi:10.1111/hpb.12223_6
SP  - 20
EP  - 39
PY  - 2014
ER  - 

TY  - JOUR
TI  - ORAL COMMUNICATIONS
JO  - British Journal of Pharmacology
VL  - 114
IS  - S1
SN  - 0007-1188
UR  - https://doi.org/10.1111/j.1476-5381.1995.tb16306.x
DO  - doi:10.1111/j.1476-5381.1995.tb16306.x
SP  - 1P
EP  - 175P
PY  - 1995
ER  - 

TY  - JOUR
TI  - British Pharmaceutical Conference 1997 Science Proceedings*
JO  - Journal of Pharmacy and Pharmacology
VL  - 49
IS  - S4
SN  - 0022-3573
UR  - https://doi.org/10.1111/j.2042-7158.1997.tb06165.x
DO  - doi:10.1111/j.2042-7158.1997.tb06165.x
SP  - 1
EP  - 120
PY  - 1997
ER  - 

TY  - JOUR
TI  - Tuesday, 7 July 1998
JO  - British Journal of Haematology
VL  - 102
IS  - 1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.1998.tb08996.x
DO  - doi:10.1111/j.1365-2141.1998.tb08996.x
SP  - 140
EP  - 269
PY  - 1998
ER  - 
